NCT05251480View on ClinicalTrials.gov

Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 1, 2026

Conditions
Diabetes MellitusUlcer FootUlcer HealingDiabetic Foot UlcerNon-healing WoundWound of SkinWound; FootTissue Injury
Interventions
PROCEDURE

Standard of Care

debridement, wound dressings, offloading

OTHER

DermGEN™

Decellularized human dermal matrix created from donated human skin

Trial Locations (1)

P0W 1C0

Northwestern Ontario (NWO) Wound Care Centre of Excellence, Emo

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Dalhousie University

OTHER

collaborator

Lakehead University

OTHER

lead

DeCell Technologies Inc.

INDUSTRY

NCT05251480 - Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People | Biotech Hunter | Biotech Hunter